References
- Bolhassani A, Safaiyan S, Rafati S (2011). Improvement of different vaccine delivery systems for cancer therapy. Mol Cancer, 10, 3.
- Cole DJ, Gattoni-Celli S, McClay EF, et al (1997). Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix. Clin Cancer Res, 3, 867-73.
- Fischer TH, Thatte HS, Nichols TC, et al (2005). Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber-mediated hemostasis. Biomaterials, 26, 5433-43. https://doi.org/10.1016/j.biomaterials.2005.01.023
- Kumar SS, Puttaraju HP (2012). Improvised microinjection technique for mosquito vectors. Indian J Med Res, 136, 971-8.
- Liu SX, Xia ZS, Zhong,YQ (2014). Gene therapy in pancreatic cancer. World J Gastroenterol, 20, 13343-68. https://doi.org/10.3748/wjg.v20.i37.13343
- Luo D, Saltzman WM (2000). Synthetic DNA delivery systems. Nat Biotechnol, 18, 33-7. https://doi.org/10.1038/71889
- Maitre N, Brown JM, Demcheva M, et al (1999). Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Clin Cancer Res, 5, 1173-82.
- Nayerossadat N, Maedeh T, Ali PA (2012). Viral and nonviral delivery systems for gene delivery. Adv Biomed Res, 1, 27. https://doi.org/10.4103/2277-9175.98152
- Patil SD, Rhodes DG, Burgess DJ (2005). DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J, 7, 61-77. https://doi.org/10.1208/aapsj070109
- Potter H, Heller R (2011). Transfection by electroporation. Curr Protoc Neurosci Appendix, 1, 1. https://doi.org/10.3923/crn.2011.1.14
- Rosenberg SA, Spiess P, Lafreniere R (1986). A new approach to the adoptive immunotherapy of cancer with tumorinfiltrating lymphocytes. Science, 233, 1318-21. https://doi.org/10.1126/science.3489291
- Salem ML, Attia WY, Al-Bolkiny YE, et al (2010b). Using poly-N-acetyl glucosamine gel matrix to deliver IL-12 with antischistosomasis vaccination. J Infect Dev Ctries, 4, 318-28.
- Salem ML, Shoukry NM, Zidan, AA (2014a). Vournakis, J., Immunomodulatory effects of IL-12 released from poly-N-acetyl glucosamine gel matrix during schistosomiasis infection. Cytotechnol, 66, 667-75; https://doi.org/10.1007/s10616-013-9620-0
- Vournakis JN, Demcheva M, Whitson A, Guirca R, Pariser ER (2004). Isolation, purification, and characterization of poly-N-acetyl glucosamine use as a hemostatic agent. J Trauma, 57, 2-6. https://doi.org/10.1097/01.TA.0000136741.66698.9D
- Vournakis JN, Demcheva MV (2012). Compositions and methods for nanopolymer-based nucleic acid delivery. Google Patents.
-
Vournakis JN, Finkielsztein S, Pariser ER, Helton M (1997) Poly-
${\beta}$ -$1^{\rightarrow}$ -4-N-acetylglucosamine. Google Patents: .